Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetor for Hereditary and Acquired Angioedema
NCT00125151Phase 3Completed
- Sponsor
- Prothya Biosolutions
- Start
- Feb 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of C1 inhibitor, human in hereditary angioedema (HAE), acquired angioedema (AAE), sponsored by Prothya Biosolutions. Started Feb 2006; status: completed.
02
Drugs
C1 inhibitor, human
03
Conditions
hereditary angioedema (HAE)acquired angioedema (AAE)
Beyond the preview
Go deeper on NCT00125151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00125151.